168 related articles for article (PubMed ID: 29156506)
1. Lower gastrointestinal bleeding in patients with coronary artery disease on antithrombotics and subsequent mortality risk.
Patel P; Nigam N; Sengupta N
J Gastroenterol Hepatol; 2018 Jun; 33(6):1185-1191. PubMed ID: 29156506
[TBL] [Abstract][Full Text] [Related]
2. Resumption of Warfarin After Hospitalization for Lower Gastrointestinal Bleeding and Mortality Benefits.
Patel P; Nigam N; Sengupta N
J Clin Gastroenterol; 2018 Jul; 52(6):545-550. PubMed ID: 28266939
[TBL] [Abstract][Full Text] [Related]
3. Triple antithrombotic therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation.
Kang DO; Yu CW; Kim HD; Cho JY; Joo HJ; Choi RK; Park JS; Lee HJ; Kim JS; Park JH; Hong SJ; Lim DS
Coron Artery Dis; 2015 Aug; 26(5):372-80. PubMed ID: 25768244
[TBL] [Abstract][Full Text] [Related]
4. Recurrence and mortality among patients hospitalized for acute lower gastrointestinal bleeding.
Aoki T; Nagata N; Niikura R; Shimbo T; Tanaka S; Sekine K; Kishida Y; Watanabe K; Sakurai T; Yokoi C; Akiyama J; Yanase M; Mizokami M; Uemura N
Clin Gastroenterol Hepatol; 2015 Mar; 13(3):488-494.e1. PubMed ID: 24997327
[TBL] [Abstract][Full Text] [Related]
5. Benefits and Risks of Extended Dual Antiplatelet Therapy After Everolimus-Eluting Stents.
Hermiller JB; Krucoff MW; Kereiakes DJ; Windecker S; Steg PG; Yeh RW; Cohen DJ; Cutlip DE; Massaro JM; Hsieh WH; Mauri L;
JACC Cardiovasc Interv; 2016 Jan; 9(2):138-47. PubMed ID: 26793956
[TBL] [Abstract][Full Text] [Related]
6. Risk and Benefits of Triple Therapy in Patients Undergoing Coronary Stent Implantation Requiring Oral Anticoagulation: A Meta-Analysis of 16 Studies.
Barbieri L; Verdoia M; Schaffer A; Suryapranata H; De Luca G
Cardiovasc Drugs Ther; 2016 Dec; 30(6):611-622. PubMed ID: 27757726
[TBL] [Abstract][Full Text] [Related]
7. Bleeding complications of triple antithrombotic therapy after percutaneous coronary interventions.
Faza NN; Mentias A; Parashar A; Chaudhury P; Barakat AF; Agarwal S; Wayangankar S; Ellis SG; Murat Tuzcu E; Kapadia SR
Catheter Cardiovasc Interv; 2017 Feb; 89(2):E64-E74. PubMed ID: 27220088
[TBL] [Abstract][Full Text] [Related]
8. Duration of dual antiplatelet therapy and long-term clinical outcome after coronary drug-eluting stent implantation: landmark analyses from the CREDO-Kyoto PCI/CABG Registry Cohort-2.
Tada T; Natsuaki M; Morimoto T; Furukawa Y; Nakagawa Y; Byrne RA; Kastrati A; Kadota K; Iwabuchi M; Shizuta S; Tazaki J; Shiomi H; Abe M; Ehara N; Mizoguchi T; Mitsuoka H; Inada T; Araki M; Kaburagi S; Taniguchi R; Eizawa H; Nakano A; Suwa S; Takizawa A; Nohara R; Fujiwara H; Mitsudo K; Nobuyoshi M; Kita T; Kimura T;
Circ Cardiovasc Interv; 2012 Jun; 5(3):381-91. PubMed ID: 22619260
[TBL] [Abstract][Full Text] [Related]
9. Stopping antithrombotic therapy after acute upper gastrointestinal bleeding is associated with reduced survival.
Siau K; Hannah JL; Hodson J; Widlak M; Bhala N; Iqbal TH
Postgrad Med J; 2018 Mar; 94(1109):137-142. PubMed ID: 29101296
[TBL] [Abstract][Full Text] [Related]
10. Risk of lower and upper gastrointestinal bleeding, transfusions, and hospitalizations with complex antithrombotic therapy in elderly patients.
Abraham NS; Hartman C; Richardson P; Castillo D; Street RL; Naik AD
Circulation; 2013 Oct; 128(17):1869-77. PubMed ID: 24025594
[TBL] [Abstract][Full Text] [Related]
11. Lower GI bleeding risk of nonsteroidal anti-inflammatory drugs and antiplatelet drug use alone and the effect of combined therapy.
Nagata N; Niikura R; Aoki T; Shimbo T; Kishida Y; Sekine K; Tanaka S; Okubo H; Watanabe K; Sakurai T; Yokoi C; Akiyama J; Yanase M; Mizokami M; Uemura N
Gastrointest Endosc; 2014 Dec; 80(6):1124-31. PubMed ID: 25088922
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study.
Lamberts M; Gislason GH; Lip GY; Lassen JF; Olesen JB; Mikkelsen AP; Sørensen R; Køber L; Torp-Pedersen C; Hansen ML
Circulation; 2014 Apr; 129(15):1577-85. PubMed ID: 24470482
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors for Adverse Outcomes in Patients Hospitalized With Lower Gastrointestinal Bleeding.
Sengupta N; Tapper EB; Patwardhan VR; Ketwaroo GA; Thaker AM; Leffler DA; Feuerstein JD
Mayo Clin Proc; 2015 Aug; 90(8):1021-9. PubMed ID: 26141075
[TBL] [Abstract][Full Text] [Related]
14. Duration of Triple Antithrombotic Therapy and Outcomes Among Patients Undergoing Percutaneous Coronary Intervention.
Koskinas KC; Räber L; Zanchin T; Pilgrim T; Stortecky S; Hunziker L; Blöchlinger S; Billinger M; Gartwyl F; Moro C; Moschovitis A; Jüni P; Heg D; Windecker S
JACC Cardiovasc Interv; 2016 Jul; 9(14):1473-83. PubMed ID: 27478115
[TBL] [Abstract][Full Text] [Related]
15. Examining the Risks of Major Bleeding Events in Older People Using Antithrombotics.
Nishtala PS; Jamieson HA; Hanger HC; Chyou TY; Hilmer SN
Cardiovasc Drugs Ther; 2019 Jun; 33(3):323-329. PubMed ID: 30826901
[TBL] [Abstract][Full Text] [Related]
16. Combination of low-dose aspirin and thienopyridine exacerbates small bowel injury.
Shiotani A; Honda K; Murao T; Ishii M; Fujita M; Matsumoto H; Tarumi K; Kamada T; Sakakibara T; Haruma K
Scand J Gastroenterol; 2011 Mar; 46(3):281-6. PubMed ID: 21133822
[TBL] [Abstract][Full Text] [Related]
17. Rebleeding and Mortality After Lower Gastrointestinal Bleeding in Patients Taking Antiplatelets or Anticoagulants.
Oakland K; Desborough MJ; Murphy MF; Schachter M; Jairath V
Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1276-1284.e3. PubMed ID: 29277620
[TBL] [Abstract][Full Text] [Related]
18. Etiology of gastrointestinal bleeding in patients on dual antiplatelet therapy.
Shaukat A; Waheed S; Alexander E; Washko D; Dawn B; Olyaee M; Gupta K
J Dig Dis; 2018 Feb; 19(2):66-73. PubMed ID: 29314627
[TBL] [Abstract][Full Text] [Related]
19. Antithrombotic therapy after percutaneous coronary intervention in patients requiring oral anticoagulant treatment. A meta-analysis.
Chen CF; Chen B; Zhu J; Xu YZ
Herz; 2015 Dec; 40(8):1070-83. PubMed ID: 26135462
[TBL] [Abstract][Full Text] [Related]
20. All-cause mortality and use of antithrombotics within 90 days of discharge in acutely ill medical patients.
Mahan CE; Fields LE; Mills RM; Stephenson JJ; Fu AC; Fisher MD; Spyropoulos AC
Thromb Haemost; 2015 Oct; 114(4):685-94. PubMed ID: 26202514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
